Severe disease via immunopathology and HLH-like response
Therapeutic Considerations
Antimicrobial rationale
Doxycycline mechanism
Tetracycline inhibits bacterial protein synthesis
Highly active against A phagocytophilum
Empiric early treatment
Mortality benefit with prompt therapy
Non-doxycycline therapy increases death risk
Coinfection strategy
Lyme coverage
Doxycycline also treats Lyme disease
10 day course covers concurrent Lyme
Babesiosis distinction
Does not respond to doxycycline
Atovaquone plus azithromycin if confirmed
Prevention principles
Tick avoidance
DEET-based repellents
Permethrin-treated clothing and daily tick checks
No prophylaxis after bite
Prophylactic antibiotics not recommended for anaplasmosis
Differs from single-dose Lyme prophylaxis approach
Patient Discharge Instructions
copy discharge instructions
Anaplasmosis home care
Take doxycycline exactly as prescribed until finished
Complete the full course even if feeling better
Take with food and water and avoid dairy within 2 hours
Avoid direct sun and use sunscreen due to photosensitivity
Rest and drink plenty of fluids
Warning signs to return to ER
Fever that persists or returns after 48 hours of antibiotics
Worsening headache confusion or trouble staying awake
Shortness of breath or chest pain
New bleeding bruising or tiny red skin spots
Inability to keep down medications or fluids
Follow up
Clinician follow up within 1 to 2 weeks
Repeat blood tests to confirm recovery
Discuss any new tick bites with your clinician
Tick prevention tips
Use DEET repellent and permethrin-treated clothing
Perform daily full-body tick checks after being outdoors
Remove attached ticks promptly with fine tweezers
Shower soon after outdoor activity
References
Guidelines and key sources
Guideline and society sources
CDC tickborne rickettsial diseases recommendations and reports MMWR 2016
Wilderness Medical Society clinical practice guidelines for tick-borne illness 2021
CDC Tickborne Diseases of the United States reference manual 2022
Key reviews and studies
MacQueen and Centellas Human Granulocytic Anaplasmosis Infect Dis Clin North Am 2022
Sanchez et al Lyme anaplasmosis and babesiosis JAMA 2016
Katragadda et al trends in anaplasmosis clinical features and outcomes CID 2026
Schudel et al systematic review of human granulocytotropic anaplasmosis PLoS NTD 2024
Decision support and coding
Hamilton et al clinical decision support for Anaplasma NAAT utilization J Clin Microbiol 2021
Anaplasmosis ICD-10 A77.49 other spotted fever group rickettsioses
SNOMED CT human granulocytic anaplasmosis disorder concept
SymptomDx is an educational tool for medical professionals. It does not replace clinical judgment. Verify all clinical data and drug dosages with authoritative sources.